Answers are grounded in this paper and cite their sources.
This study develops a methodologically grounded decision-support framework for product portfolio management (PPM) in manufacturing business-to-business (B2B) firms, aimed at systematically addressing the growing challenges posed by disruptive change, particularly those arising from digital and sustainable transformations. A preliminary study and systematic literature review reveal that current evaluation approaches fall short in addressing these emerging challenges. To address this gap, the proposed PPM-specific framework integrates established multi-criteria decision-making (MCDM) methods: the analytic hierarchy process (AHP), the decision-making trial and evaluation laboratory (DEMATEL), and the weighted sum model (WSM). In addition to the three established PPM target dimensions – value maximization, strategic fit, and balance – the proposed methodology introduces a fourth dimension: resilience to disruptive factors. This expanded framework enables a structured derivation and weighting of evaluation criteria, identification of interdependencies within the product portfolio, and a systematic assessment of the strategic value contribution of individual portfolio elements. A case study with a global automation technology provider and evaluation workshops with three additional globally operating B2B industrial firms demonstrate the framework's practical relevance. The results indicate enhanced transparency, more objective decision-making, and systematic portfolio governance. This research contributes a formal and transparent decision support tool that facilitates strategically robust portfolio design in times of disruptive transformation, thereby addressing critical gaps in existing literature.
No takes yet. Share an insight, caveat, or question.
Gramberg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: